质子对APCMin/+小鼠乳腺肿瘤发生的相对生物效能高于γ射线且ERα/HER2阳性率更高
该研究比较了1 GeV质子和137Cs γ射线对雌性APCMin/+小鼠乳腺肿瘤发生的影响,发现质子照射在两种剂量下均增加乳腺肿瘤频率,计算所得相对生物效能(RBE)全部肿瘤为3.11、恶性肿瘤>5,且质子诱导的肿瘤ERα和HER2阳性率及ERα下游PI3K/Akt和cyclin D1通路活化更高。
要点
- 质子照射乳腺肿瘤RBE全部肿瘤为3.11、恶性肿瘤>5。
- 质子诱导更多腺癌且ERα/HER2阳性率更高。
- 低剂量单位辐射肿瘤频率更高提示饱和效应。
核心结论
- 质子相对γ射线具有更高的乳腺肿瘤发生风险。
- 质子诱导的APCMin/+小鼠肿瘤呈ERα和HER2阳性。
研究设计与样本
- 雌性APCMin/+小鼠分别接受1 GeV质子(1.88或4.71 Gy)和137Cs γ射线(2或5 Gy)照射。
- 照射后100至110天处死小鼠,评估乳腺肿瘤、分级并计算相对生物效能。
主要发现
- 质子照射两种剂量下乳腺肿瘤频率均高于γ射线。
- 质子诱导乳腺肿瘤发生的RBE全部肿瘤为3.11,恶性肿瘤>5。
- 低剂量单位辐射肿瘤频率更高,提示高剂量饱和效应。
- 质子诱导更多腺癌,且ERα和HER2阳性率及ERα下游PI3K/Akt和cyclin D1通路活化高于γ射线。
关键数值与推荐
- 质子剂量1.88或4.71 Gy,γ射线剂量2或5 Gy。
- 全部肿瘤RBE为3.11,恶性肿瘤RBE>5。
局限性
- 需进一步研究解决空间辐射诱导乳腺癌风险估计中的不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Exposure to ionizing radiation increases risk of breast cancer. Although proton radiation is encountered in outer space and in medicine, we do not fully understand breast cancer risks from protons owing to limited in vivo data. The purpose of this study was to comparatively assess the effects of γ-rays and protons on mammary tumorigenesis in APCMin/+ mice. METHODS AND MATERIALS: Female APCMin/+ mice were exposed to 1 GeV protons (1.88 or 4.71 Gy) and 137Cs γ-rays (2 or 5 Gy). Mice were euthanized 100 to 110 days after irradiation, at which point mammary tumors were scored, tumor grades were assessed, and relative biological effectiveness was calculated. Molecular phenotypes were determined by assessing estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) status. ERα downstream signaling was assessed by immunohistochemistry. RESULTS: Exposure to proton radiation led to increased mammary tumor frequency at both proton radiation doses compared with γ-rays. The calculated relative biological effectiveness for proton radiation-induced mammary tumorigenesis was 3.11 for all tumors and >5 for malignant tumors relative to γ-rays. Tumor frequency per unit of radiation was higher at the lower dose, suggesting a saturation effect at the higher dose. Protons induced more adenocarcinomas relative to γ-rays, and proton-induced tumors show greater ERα and HER2 positivity and higher activation of the ERα downstream PI3K/Akt and cyclin D1 pathways relative to γ-rays. CONCLUSIONS: Our data demonstrate that protons pose a higher risk of mammary tumorigenesis relative to γ-rays. We also show that proton radiation-induced tumors in APCMin/+ mice are ERα- and HER2-positive, which is consistent with our previous data on radiation-induced estrogenic response in wild-type mice. Although this study establishes APCMin/+ as a model with adequate signal-to-noise ratio for space radiation-induced mammary tumorigenesis, further studies will be required to address the uncertainties in space radiation-induced breast cancer risk estimation.
引用
- Suman S, Shuryak I, Kallakury B, et al. Protons Show Greater Relative Biological Effectiveness for Mammary Tumorigenesis with Higher ERα- and HER2-Positive Tumors Relative to γ-rays in APCMin/+ Mice. Int J Radiat Oncol Biol Phys. 2020. PMID: 32036005. doi:10.1016/j.ijrobp.2020.01.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。